CD19 Mouse Monoclonal Antibody [Clone ID: OTI5F3]
CAT#: TA500363
Anti-CD19 mouse monoclonal antibody, clone OTI5F3 (formerly 5F3)
Size: 30 ul
Formulation: Carrier Free
USD 436.00
Specifications
| Product Data | |
| Clone Name | OTI5F3 |
| Applications | WB |
| Recommended Dilution | WB 1:1000 |
| Reactivities | Human |
| Host | Mouse |
| Isotype | IgG1 |
| Clonality | Monoclonal |
| Immunogen | Full-length protein expressed in 293T cell transfected with human CD19 expression vector |
| Formulation | PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. |
| Concentration | 0.65 mg/ml |
| Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) |
| Conjugation | Unconjugated |
| Storage | Store at -20°C as received. |
| Stability | Stable for 12 months from date of receipt. |
| Predicted Protein Size | 61.13 kDa |
| Gene Name | CD19 molecule |
| Database Link | |
| Background | Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation. |
| Synonyms | B4; CVID3 |
| Reference Data | |
| Protein Families | Druggable Genome, Transmembrane |
| Protein Pathways | B cell receptor signaling pathway, Hematopoietic cell lineage, Primary immunodeficiency |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
| Antibody Resources |
{0} Product Review(s)
Be the first one to submit a review
Germany
Japan
United Kingdom
China